These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25384351)

  • 1. Atypical femoral fracture in osteoporosis pseudoglioma syndrome associated with two novel compound heterozygous mutations in LRP5.
    Alonso N; Soares DC; V McCloskey E; Summers GD; Ralston SH; Gregson CL
    J Bone Miner Res; 2015 Apr; 30(4):615-20. PubMed ID: 25384351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporosis-pseudoglioma syndrome: clinical, genetic, and treatment-response study of 10 new cases in Greece.
    Papadopoulos I; Bountouvi E; Attilakos A; Gole E; Dinopoulos A; Peppa M; Nikolaidou P; Papadopoulou A
    Eur J Pediatr; 2019 Mar; 178(3):323-329. PubMed ID: 30499050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass.
    Ren N; Lv S; Li X; Shao C; Wang Z; Mei Y; Yang W; Fu W; Hu Y; Sha L; Hu W; Zhang Z; Wang C
    Osteoporos Int; 2024 Aug; 35(8):1395-1406. PubMed ID: 38625381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Homozygous LRP5 Mutations in Mexican Patients with Osteoporosis-Pseudoglioma Syndrome.
    Astiazarán MC; Cervantes-Sodi M; Rebolledo-Enríquez E; Chacón-Camacho O; Villegas V; Zenteno JC
    Genet Test Mol Biomarkers; 2017 Dec; 21(12):742-746. PubMed ID: 29131652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis-pseudoglioma syndrome: three novel mutations in the LRP5 gene and response to bisphosphonate treatment.
    Tüysüz B; Bursalı A; Alp Z; Suyugül N; Laine CM; Mäkitie O
    Horm Res Paediatr; 2012; 77(2):115-20. PubMed ID: 22456437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporosis-pseudoglioma syndrome in four new patients: identification of two novel LRP5 variants and insights on patients' management using bisphosphonates therapy.
    Abdel-Hamid MS; Elhossini RM; Otaify GA; Abdel-Ghafar SF; Aglan MS
    Osteoporos Int; 2022 Jul; 33(7):1501-1510. PubMed ID: 35106624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG).
    Celli M; D'Eufemia P; Persiani P; Turchetti A; Febbo A; D'Alfonso Y; Celli L; Zambrano A
    Osteoporos Int; 2017 Nov; 28(11):3277-3280. PubMed ID: 28866852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A family with osteoporosis pseudoglioma syndrome due to compound heterozygosity of two novel mutations in the LRP5 gene.
    Cheung WM; Jin LY; Smith DK; Cheung PT; Kwan EY; Low L; Kung AW
    Bone; 2006 Sep; 39(3):470-6. PubMed ID: 16679074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity.
    Korvala J; Jüppner H; Mäkitie O; Sochett E; Schnabel D; Mora S; Bartels CF; Warman ML; Deraska D; Cole WG; Hartikka H; Ala-Kokko L; Männikkö M
    BMC Med Genet; 2012 Apr; 13():26. PubMed ID: 22487062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG).
    Laine CM; Chung BD; Susic M; Prescott T; Semler O; Fiskerstrand T; D'Eufemia P; Castori M; Pekkinen M; Sochett E; Cole WG; Netzer C; Mäkitie O
    Eur J Hum Genet; 2011 Aug; 19(8):875-81. PubMed ID: 21407258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractures on bisphosphonates in osteoporosis pseudoglioma syndrome (OPPG): pQCT shows poor bone density and structure.
    Streeten EA; Ramirez S; Eliades M; Jaimungal S; Chandrasekaran S; Kathleen R; Holmes Morton D; Puffenberger EG; Herskovitz R; Leonard MB
    Bone; 2015 Aug; 77():17-23. PubMed ID: 25892485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three years follow-up of pamidronate therapy in two brothers with osteoporosis-pseudoglioma syndrome (OPPG) carrying an LRP5 mutation.
    Barros ER; Dias da Silva MR; Kunii IS; Lazaretti-Castro M
    J Pediatr Endocrinol Metab; 2008 Aug; 21(8):811-8. PubMed ID: 18825883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerostin inhibition reverses skeletal fragility in an Lrp5-deficient mouse model of OPPG syndrome.
    Kedlaya R; Veera S; Horan DJ; Moss RE; Ayturk UM; Jacobsen CM; Bowen ME; Paszty C; Warman ML; Robling AG
    Sci Transl Med; 2013 Nov; 5(211):211ra158. PubMed ID: 24225945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital Bilateral Retinal Detachment in Two Siblings with Osteoporosis-Pseudoglioma Syndrome.
    Welinder LG; Robitaille JM; Rupps R; Boerkoel CF; Lyons CJ
    Ophthalmic Genet; 2015; 36(3):276-80. PubMed ID: 25945592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporosis-Pseudoglioma in a Mauritanian Child due to a Novel Mutation in LRP5.
    Biha N; Ghaber SM; Hacen MM; Collet C
    Case Rep Genet; 2016; 2016():9814928. PubMed ID: 26904320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and management of osteoporosis-pseudoglioma syndrome.
    Levasseur R
    Expert Rev Endocrinol Metab; 2008 May; 3(3):337-348. PubMed ID: 30754200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel LRP5 gene mutation in a patient with osteoporosis-pseudoglioma syndrome.
    Marques-Pinheiro A; Levasseur R; Cormier C; Bonneau J; Boileau C; Varret M; Abifadel M; Allanore Y
    Joint Bone Spine; 2010 Mar; 77(2):151-3. PubMed ID: 20096619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy-associated osteoporosis with a heterozygous deactivating LDL receptor-related protein 5 (LRP5) mutation and a homozygous methylenetetrahydrofolate reductase (MTHFR) polymorphism.
    Cook FJ; Mumm S; Whyte MP; Wenkert D
    J Bone Miner Res; 2014 Apr; 29(4):922-8. PubMed ID: 24014470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular findings in osteoporosis-pseudoglioma syndrome.
    Ai M; Heeger S; Bartels CF; Schelling DK;
    Am J Hum Genet; 2005 Nov; 77(5):741-53. PubMed ID: 16252235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRP5, Bone Mass Polymorphisms and Skeletal Disorders.
    Littman J; Yang W; Olansen J; Phornphutkul C; Aaron RK
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.